Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8+ T cells during persistent infection

Blood

Volumn 106, Issue 2, 2005, Pages 558-565

  Dunne, Pádraic J ^b   Belaramani, Lavina ^b   Fletcher, Jean M ^b   Fernandez De Mattos, Silvia ^b   Lawrenz, Maria ^b   Soares, Maria Vieira D ^b   Rustin, Malcolm H A ^b   Lam, Eric W F ^b   Salmon, Mike ^b   Akbar, Arne N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD45 ANTIGEN; CD8 ANTIGEN; CYCLIN INHIBITOR; INTERLEUKIN 15; PROTEIN P27; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; EFFECTOR CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; MEDIATOR RELEASE; MEMORY CELL; PERSISTENT INFECTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 22144447518     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-11-4469     Document Type: Article

References (48)

1. Zinkernagel RM, Bachmann MF, Kundig TM, et al. On immunological memory. Annu Rev Immunol. 1996;14:333-367.
2. Akbar AN, Salmon M. Cellular environments and apoptosis: tissue microenvironments control activated T cell death. Immunol Today. 1997;18:72-76.
3. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol. 1997;15:405-431.
4. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002;169:1984-1992.
5. Hodes RJ, Hathcock KS, Weng NP. Telomeres in T and B cells. Nat Rev Immunol. 2002;2:699-706.
6. Akbar AN, Beverley PC, Salmon M. Will telomere erosion lead to a loss of T-cell memory? Nat Rev Immunol. 2004;4:737-743.
7. + T cells compromise both naive and memory cells. J Immunol. 1999;162:7080-7087.
8. + T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood. 2002;100:933-940.
9. Grubeck-Loebenstein B, Wick G. The aging of the immune system. Adv Immunol. 2002;80:243-284.
10. Champagne P, Ogg GS, King AS, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 2001;410:106-111.
11. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708-712.
12. van Lier RA, ten Berge IJ, Gamadia LE. Human CD8(+) T-cell differentiation in response to viruses. Nat Rev Immunol. 2003;3:931-939.
13. + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood. 2003;101:4260-4266.
14. Wallace DL, Zhang Y, Ghattas H, et al. Direct measurement of T cell subset kinetics in vivo in elderly men and women. J Immunol. 2004;173:1787-1794.
15. Balomenos D, Martinez-AC. Cell-cycle regulation in immunity, tolerance and autoimmunity. Immunol Today. 2000;21:551-555.
16. Walworth NC. Cell-cycle checkpoint kinases: checking in on the cell cycle. Curr Opin Cell Biol. 2000;12:697-704.
17. Yusuf I, Fruman DA. Regulation of quiescence in lymphocytes. Trends Immunol. 2003;24:380-386.
18. Kip1. J Immunol. 2000;165:6270-5277.
19. Pilling D, Akbar AN, Girdlestone J, et al. Interferon-β mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol. 1999;29:1041-1050.
20. + T cells. J Immunol. 2000;165:3782-3789.
21. Grander D, Sangfelt O, Erickson S. How does Interferon exert its cell growth inhibitory effect? Eur J Haematol. 1997;59:129-135.
22. De Maeyer E, De Maeyer-Guignard J. Type I interferon. Int Rev Immunol. 1998;17:53-73.
23. + T cells during acute Epstein Barr virus infection. Blood. 2001;97:1-8.
24. + T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. J Immunol. 2001;167:2019-2029.
25. Reed JR, Vukmanovic-Stejic M, Fletcher JM, et al. Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med. 2004;199:1433-1443.
26. + T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003;281:65-78.
27. + T cells from blood and tonsils during primary infection. Blood. 2004;103:162-167.
28. Akbar AN, Borthwick NJ, Salmon M, et al. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med. 1993;178:427-438.
29. Moro A, Santos A, Arana MJ, Perea SE. Activation of the human p27Kip1 promoter by IFNα 2b. Biochem Biophys Res Commun. 2000;269:31-34.
30. L expression. Immunology. 1996;89:397-404.
31. Sprent J, Tough DF. T cell death and memory. Science. 2001;293:245-248.
32. Sprent J, Surh CD. Generation and maintenance of memory T cells. Curr Opin Immunol. 2001;13:248-254.
33. Gourley TS, Wherry EJ, Masopust D, Ahmed R. Generation and maintenance of immunological memory. Semin Immunol. 2004;16:323-333.
34. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol. 2003;3:269-279.
35. Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Exp Med. 1999;189:521-529.
36. McHeyzer-Williams M, McHeyzer-Williams L, Panus J, et al. Helper T-cell-regulated B-cell immunity. Microbes Infect. 2003;5:205-212.
37. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene. 1998;17:1027-1037.
38. Veiga-Fernandes H, Rocha B. High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division. Nat Immunol. 2004;5:31-37.
39. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172:2731-2738.
40. Erickson S, Sangfelt O, Castro J, et al. Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin-2-induced changes in cell-cycle-regulatory proteins. Cell Growth Differ. 1999;10:575-582.
41. + T cells during the primary immune responses to Epstein-Barr virus in vivo. J Exp Med. 1998;187:1395-1402.
42. + T subsets with distinct replicative history and partial effector functions. Blood. 2003;102:1779-1787.
43. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8:379-385.
44. high 'revertant' CD4 memory T cells provide help for memory B cells. Eur J Immunol. 2001;31:1685-1695.
45. + pool with distinct phenotypic and migratory characteristics. J Immunol. 2001; 167:212-220.
46. + T-cell maturation: CD27 might provide a due. Trends Immunol. 2002;23:586-591.
47. + T cells. Proc Natl Acad Sci USA. 2004;101:1969-1974.
48. Waldmann TA. The IL-2/IL-15 receptor systems: targets for immunotherapy. J Clin Immunol. 2002; 22:51-56.